Get the Stockscreener App
1.14
8.06%
-0.10
After Hours:
1.06
-0.08
-7.02%
Zyversa Therapeutics Inc Stock (ZVSA) Forecast
The Zyversa Therapeutics Inc (ZVSA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.2221, representing a +533.52% increase from the current price of $1.14. The highest analyst price target is $7.4122, and the lowest is $7.0321.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ZVSA Price Target
Average 11.95
(+947.83% Upside)
Is Zyversa Therapeutics Inc (ZVSA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.67 | Neutral |
| STOCH(9,6) | 33.91 | Neutral |
| STOCHRSI(14) | 74.44 | Neutral |
| MACD(12,26) | -0.0945 | Buy |
| ADX(14) | 14.17 | Neutral |
| William %R | -63.65 | Neutral |
| CCI(14) | 112.60 | Buy |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.0965
Buy
|
1.1059
Buy
|
| MA20 |
1.0761
Buy
|
1.1453
Sell
|
| MA50 |
1.515
Sell
|
1.49
Sell
|
| MA100 |
2.0984
Sell
|
2.1444
Sell
|
| MA200 |
3.7948
Sell
|
2.9051
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, ZVSA could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ZVSA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.67 indicates that ZVSA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 33.91 indicates that ZVSA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 74.44 indicates that ZVSA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.17 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 112.6 indicates that ZVSA is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term ZVSA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Zyversa Therapeutics Inc financial reports and earnings history, Zyversa Therapeutics Inc (ZVSA) stock could reach $31.21 by 2030, $52.38 by 2040 and $171.48 by 2050. See the projected annual prices until 2050 of the Zyversa Therapeutics Inc stock below:
- Zyversa Therapeutics Inc (ZVSA) is expected to reach an average price of $46.14 in 2035, with a high prediction of $46.16 and a low estimate of $42.61. This indicates an $3,947% rise from the last recorded price of $1.14.
- Zyversa Therapeutics Inc (ZVSA) stock is projected to chart a bullish course in 2040, with an average price target of $52.29, representing an $4,487% surge from its current level. The forecast ranges from a conservative $48.13 to a sky-high $52.38.
- Our analysts predict Zyversa Therapeutics Inc (ZVSA) to jump 13,513% by 2045, soaring from $150.33 to an average price of $155.19, potentially reaching $155.28. While $150.33 is the low estimate, the potential upside is significant.
- Zyversa Therapeutics Inc (ZVSA) stock is expected to climb by 2050, reaching an average of $171.45, a $14,940% jump from its current level. However, a wide range of estimates exists, with high and low targets of $171.48 and $165.55, respectively, highlighting the market's uncertainty.
Zyversa Therapeutics Inc Stock (ZVSA) Year by Year Forecast
Zyversa Therapeutics Inc Stock (ZVSA) Price Forecast for 2025
Zyversa Therapeutics Inc Stock (ZVSA) is expected to reach an average price of $11.95 in 2025, with a high prediction of $16.86 and a low estimate of $7.0321. This indicates an +947.83% rise from the last recorded price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.3915 | $7.0321 | $7.4122 | +548.38% |
| February, 2025 | $7.79 | $7.4965 | $7.7923 | +583.33% |
| March, 2025 | $9.0347 | $7.8853 | $10.86 | +692.52% |
| April, 2025 | $9.2108 | $8.9383 | $9.3107 | +707.96% |
| May, 2025 | $9.8464 | $9.3214 | $9.8854 | +763.72% |
| June, 2025 | $10.23 | $10.08 | $11.65 | +797.43% |
| July, 2025 | $10.54 | $10.31 | $10.69 | +824.75% |
| August, 2025 | $8.72 | $8.72 | $16.86 | +664.91% |
| September, 2025 | $9.5595 | $8.7374 | $9.9324 | +738.55% |
| October, 2025 | $9.2036 | $8.5998 | $10.76 | +707.33% |
| November, 2025 | $9.9869 | $9.3748 | $9.9963 | +776.05% |
| December, 2025 | $10.85 | $10.07 | $10.87 | +851.89% |
Zyversa Therapeutics Inc Stock (ZVSA) Price Forecast for 2026
The predicted value for Zyversa Therapeutics Inc (ZVSA) in 2026 is set at an average of $19.01. Estimates vary from a peak of $27.02 to a trough of $11.00, indicating an +1,567% surge from the present price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $11.58 | $11.00 | $11.59 | +916.00% |
| February, 2026 | $12.36 | $11.77 | $12.37 | +984.57% |
| March, 2026 | $13.16 | $12.56 | $13.18 | +1,055% |
| April, 2026 | $14.15 | $13.35 | $14.17 | +1,142% |
| May, 2026 | $14.93 | $14.32 | $14.95 | +1,210% |
| June, 2026 | $16.56 | $15.13 | $18.69 | +1,353% |
| July, 2026 | $17.43 | $16.54 | $17.58 | +1,429% |
| August, 2026 | $18.07 | $17.38 | $18.13 | +1,485% |
| September, 2026 | $19.54 | $18.23 | $20.79 | +1,614% |
| October, 2026 | $20.06 | $19.45 | $20.15 | +1,659% |
| November, 2026 | $25.10 | $20.19 | $26.31 | +2,102% |
| December, 2026 | $12.98 | $12.20 | $27.02 | +1,038% |
Zyversa Therapeutics Inc Stock (ZVSA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Zyversa Therapeutics Inc (ZVSA) is $20.07, with a high forecast of $27.45 and a low forecast of $12.69. This indicates an +1,661% increase from the last price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $12.73 | $12.69 | $14.85 | +1,016% |
| February, 2027 | $13.87 | $13.02 | $13.99 | +1,117% |
| March, 2027 | $15.25 | $14.14 | $15.31 | +1,238% |
| April, 2027 | $16.41 | $15.54 | $16.47 | +1,339% |
| May, 2027 | $17.59 | $16.67 | $17.59 | +1,443% |
| June, 2027 | $19.07 | $17.88 | $19.10 | +1,572% |
| July, 2027 | $20.27 | $19.35 | $20.33 | +1,678% |
| August, 2027 | $21.45 | $20.57 | $21.48 | +1,782% |
| September, 2027 | $22.95 | $21.75 | $23.01 | +1,913% |
| October, 2027 | $24.92 | $23.24 | $26.52 | +2,086% |
| November, 2027 | $25.86 | $25.18 | $26.16 | +2,169% |
| December, 2027 | $27.42 | $26.16 | $27.45 | +2,305% |
Zyversa Therapeutics Inc Stock (ZVSA) Price Forecast for 2028
In 2028, Zyversa Therapeutics Inc (ZVSA) is projected to reach an average price of $26.43, with a high projection of $37.18 and a low estimate of $15.68. This indicates an +2,218% rise from the last price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $29.00 | $27.71 | $29.94 | +2,444% |
| February, 2028 | $29.99 | $29.10 | $30.05 | +2,531% |
| March, 2028 | $33.72 | $30.26 | $37.18 | +2,858% |
| April, 2028 | $16.86 | $15.68 | $17.12 | +1,379% |
| May, 2028 | $17.62 | $16.77 | $18.94 | +1,445% |
| June, 2028 | $19.15 | $17.93 | $19.20 | +1,580% |
| July, 2028 | $20.64 | $19.55 | $20.66 | +1,711% |
| August, 2028 | $22.59 | $21.03 | $22.59 | +1,882% |
| September, 2028 | $24.19 | $22.98 | $24.20 | +2,022% |
| October, 2028 | $25.81 | $24.58 | $25.89 | +2,164% |
| November, 2028 | $27.81 | $26.19 | $27.82 | +2,339% |
| December, 2028 | $29.37 | $28.19 | $29.39 | +2,476% |
Zyversa Therapeutics Inc Stock (ZVSA) Price Forecast for 2029
The 2029 price forecast for Zyversa Therapeutics Inc Stock (ZVSA) is $33.25 on average, with a high prediction of $47.33 and a low estimate of $19.16. This represents an +2,816% increase from the previous price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $32.22 | $29.78 | $34.35 | +2,727% |
| February, 2029 | $33.82 | $32.40 | $33.92 | +2,867% |
| March, 2029 | $35.13 | $34.10 | $35.23 | +2,982% |
| April, 2029 | $36.98 | $35.55 | $37.02 | +3,144% |
| May, 2029 | $39.02 | $37.52 | $39.23 | +3,323% |
| June, 2029 | $40.41 | $39.32 | $40.55 | +3,445% |
| July, 2029 | $19.16 | $19.16 | $47.33 | +1,581% |
| August, 2029 | $21.60 | $19.48 | $21.84 | +1,795% |
| September, 2029 | $22.38 | $20.86 | $23.03 | +1,863% |
| October, 2029 | $24.81 | $22.85 | $24.88 | +2,077% |
| November, 2029 | $26.76 | $25.23 | $26.78 | +2,247% |
| December, 2029 | $28.70 | $27.21 | $28.71 | +2,418% |
Zyversa Therapeutics Inc Stock (ZVSA) Price Forecast for 2030
Zyversa Therapeutics Inc Stock (ZVSA) is expected to reach an average price of $40.07 in 2030, with a high forecast of $57.49 and a low forecast of $22.64. This signifies an +3,415% surge from the last price of $1.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $31.20 | $29.19 | $31.21 | +2,637% |
| February, 2030 | $33.21 | $31.68 | $33.23 | +2,814% |
| March, 2030 | $35.22 | $33.71 | $35.23 | +2,989% |
| April, 2030 | $37.21 | $35.69 | $37.23 | +3,164% |
| May, 2030 | $40.44 | $37.71 | $42.19 | +3,447% |
| June, 2030 | $42.44 | $40.91 | $42.59 | +3,623% |
| July, 2030 | $44.80 | $42.69 | $44.85 | +3,830% |
| August, 2030 | $47.28 | $45.28 | $48.23 | +4,047% |
| September, 2030 | $49.01 | $47.50 | $49.10 | +4,199% |
| October, 2030 | $56.08 | $49.45 | $57.49 | +4,820% |
| November, 2030 | $24.02 | $22.64 | $57.20 | +2,007% |
| December, 2030 | $24.99 | $24.42 | $27.11 | +2,092% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):